{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:11:21Z","timestamp":1794028281515,"version":"4.8.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Endogenous Cushing's syndrome (CS) has been linked with an increased risk of cancer. We aimed to evaluate the association between cancer risk and disease remission postsurgery in adrenal CS and Cushing's disease (CD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A nationwide retrospective matched-cohort study of patients with CS diagnosed between 2000 and 2023 in Israel, using Clalit Health Services\u2019 database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with CS were matched 1:5 with controls by age, sex, socioeconomic status, and BMI. Remission status postsurgery was assessed within 2 years after the diagnosis of CS. The outcome measured was time to first diagnosis of malignancy, at least 3 years post-CS diagnosis, excluding those who died or developed cancer earlier. Malignancy risk, stratified by remission status, was evaluated using Cox proportional hazards with death as a competing event.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort comprised 388 cases and 1862 controls [mean age at diagnosis, 47.4 \u00b1 16.8 years; 1534 (68.2%) women]. Among patients with CD, those who did not achieve remission within 2 years postdiagnosis (n = 69) had a higher risk of malignancy compared to those who achieved remission (n = 99) (HR 3.89, 95% CI 1.41-10.75). Cancer risk in patients with CD who achieved remission was similar to that of the controls (HR 0.58, 95% CI .23-1.47). In patients with adrenal CS, the risk of cancer was comparable between those who did not achieve early remission (n = 39) and those who did (n = 113) (HR 1.68, 95% CI .83-3.40).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Though cancer risk is higher in both CD and adrenal CS, we have shown that achieving surgical remission within 2 years may attenuate cancer risk in patients with CD, but not in those with adrenal CS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf028","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:01:28Z","timestamp":1740459688000},"page":"266-276","source":"Crossref","is-referenced-by-count":9,"title":["Impact of remission status in endogenous Cushing's syndrome on cancer incidence"],"prefix":"10.1093","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-6321","authenticated-orcid":false,"given":"Yaron","family":"Rudman","sequence":"first","affiliation":[{"name":"Rabin Medical Center, Institute of Endocrinology, Beilinson Hospital , Petah Tikva 4941492 ,","place":["Israel"]},{"name":"Faculty of Medical & Health Sciences, Tel Aviv University , Tel Aviv 6997801 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[{"name":"Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health and Science University , Portland, OR ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-8025","authenticated-orcid":false,"given":"Hiba","family":"Masri-Iraqi","sequence":"additional","affiliation":[{"name":"Rabin Medical Center, Institute of Endocrinology, Beilinson Hospital , Petah Tikva 4941492 ,","place":["Israel"]},{"name":"Faculty of Medical & Health Sciences, Tel Aviv University , Tel Aviv 6997801 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7576-8327","authenticated-orcid":false,"given":"Tzipora","family":"Shochat","sequence":"additional","affiliation":[{"name":"Biostatistics Unit, Rabin Medical Center, Beilinson Hospital , Petah Tikva 4941492 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2359-5249","authenticated-orcid":false,"given":"Shiri","family":"Kushnir","sequence":"additional","affiliation":[{"name":"Research Authority, Rabin Medical Center, Beilinson Hospital , Petah Tikva 4941492 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-3894","authenticated-orcid":false,"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[{"name":"Rabin Medical Center, Institute of Endocrinology, Beilinson Hospital , Petah Tikva 4941492 ,","place":["Israel"]},{"name":"Faculty of Medical & Health Sciences, Tel Aviv University , Tel Aviv 6997801 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9376-344X","authenticated-orcid":false,"given":"Amit","family":"Akirov","sequence":"additional","affiliation":[{"name":"Rabin Medical Center, Institute of Endocrinology, Beilinson Hospital , Petah Tikva 4941492 ,","place":["Israel"]},{"name":"Faculty of Medical & Health Sciences, Tel Aviv University , Tel Aviv 6997801 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"2","key":"2025031205572044000_lvaf028-B1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"issue":"10418","key":"2025031205572044000_lvaf028-B2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","article-title":"Cushing's syndrome","volume":"402","author":"Gadelha","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"2025031205572044000_lvaf028-B3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2025031205572044000_lvaf028-B4","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing's syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025031205572044000_lvaf028-B5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"2025031205572044000_lvaf028-B6","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1159\/000540205","article-title":"Cushing's disease may have higher incidence than previously thought: a nationwide study in Iceland 2010-2019","volume":"114","author":"Matthiasdottir","year":"2024","journal-title":"Neuroendocrinology"},{"issue":"4","key":"2025031205572044000_lvaf028-B7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing's disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2025031205572044000_lvaf028-B8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing's syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2025031205572044000_lvaf028-B9","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/clinem\/dgac265","article-title":"The effect of endogenous Cushing syndrome on all-cause and cause-specific mortality","volume":"107","author":"Limumpornpetch","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025031205572044000_lvaf028-B10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing's syndrome in New Zealand [published correction appears in Clin Endocrinol (Oxf). 2020 Jul;93(1). doi: 10.1111\/cen.14249]","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2025031205572044000_lvaf028-B11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/ejendo\/lvae098","article-title":"Endogenous Cushing's syndrome and cancer risk","volume":"191","author":"Rudman","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2025031205572044000_lvaf028-B12","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae405","article-title":"Cushing's syndrome is associated with a higher risk of cancer\u2014a nationwide cohort study","author":"Wu","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025031205572044000_lvaf028-B13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1530\/EJE-19-0695","article-title":"Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease","volume":"182","author":"Newell-Price","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025031205572044000_lvaf028-B14","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1016\/S1470-2045(13)70598-9","article-title":"Addressing overdiagnosis and overtreatment in cancer: a prescription for change","volume":"15","author":"Esserman","year":"2014","journal-title":"Lancet Oncol"},{"issue":"8","key":"2025031205572044000_lvaf028-B15","doi-asserted-by":"publisher","first-page":"dgaa291","DOI":"10.1210\/clinem\/dgaa291","article-title":"Excess morbidity persists in patients with Cushing's disease during long-term remission: a Swedish nationwide study","volume":"105","author":"Papakokkinou","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025031205572044000_lvaf028-B16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1530\/EJE-13-0320","article-title":"Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center","volume":"169","author":"Yaneva","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025031205572044000_lvaf028-B17","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with Cushing disease: a Swedish nationwide study","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025031205572044000_lvaf028-B18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1530\/EJE-13-0569","article-title":"Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up","volume":"169","author":"Ntali","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2025031205572044000_lvaf028-B19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2025031205572044000_lvaf028-B20","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1210\/jc.2011-3123","article-title":"Body composition and cardiovascular risk markers after remission of Cushing's disease: a prospective study using whole-body MRI","volume":"97","author":"Geer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025031205572044000_lvaf028-B21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/cen.13230","article-title":"Proinflammatory cytokines remain elevated despite long-term remission in Cushing's disease: a prospective study","volume":"86","author":"Shah","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2025031205572044000_lvaf028-B22","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/s41416-024-02857-7","article-title":"Association of metabolic obesity phenotypes with risk of overall and site-specific cancers: a systematic review and meta-analysis of cohort studies","volume":"131","author":"Mahamat-Saleh","year":"2024","journal-title":"Br J Cancer"},{"issue":"12","key":"2025031205572044000_lvaf028-B23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41574-024-01032-5","article-title":"The multifactorial effect of obesity on the effectiveness and outcomes of cancer therapies","volume":"20","author":"Lysaght","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"9612","key":"2025031205572044000_lvaf028-B24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"2025031205572044000_lvaf028-B25","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.2337\/dc20-0204","article-title":"Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people","volume":"43","author":"Ling","year":"2020","journal-title":"Diabetes Care"},{"issue":"3","key":"2025031205572044000_lvaf028-B26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1530\/EJE-11-1095","article-title":"The burden of Cushing's disease: clinical and health-related quality of life aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025031205572044000_lvaf028-B27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1530\/EJE-21-0458","article-title":"Abnormal body composition in patients with adrenal adenomas","volume":"185","author":"Delivanis","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2025031205572044000_lvaf028-B28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41574-023-00868-7","article-title":"An individualized approach to the management of Cushing disease","volume":"19","author":"Fleseriu","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2025031205572044000_lvaf028-B29","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025031205572044000_lvaf028-B30","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1210\/jcem.84.8.5896","article-title":"Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025031205572044000_lvaf028-B31","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1210\/jc.2009-0766","article-title":"Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome","volume":"94","author":"Barahona","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025031205572044000_lvaf028-B32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/ejendo\/lvad008","article-title":"Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome","volume":"188","author":"Amodru","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025031205572044000_lvaf028-B33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025031205572044000_lvaf028-B34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s12020-018-1709-y","article-title":"Cushing's syndrome: comparison between Cushing's disease and adrenal Cushing's","volume":"62","author":"Hirsch","year":"2018","journal-title":"Endocrine"},{"issue":"2","key":"2025031205572044000_lvaf028-B35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","article-title":"Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center","volume":"58","author":"Patrova","year":"2017","journal-title":"Endocrine"},{"issue":"7","key":"2025031205572044000_lvaf028-B36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2025031205572044000_lvaf028-B37","doi-asserted-by":"publisher","first-page":"dgz136","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to diagnosis in Cushing's syndrome: a meta-analysis based on 5367 patients","volume":"105","author":"Rubinstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025031205572044000_lvaf028-B38","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1210\/jc.2012-2893","article-title":"Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients","volume":"98","author":"Lambert","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025031205572044000_lvaf028-B39","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1507\/endocrj.EJ14-0155","article-title":"Long-term study of subclinical Cushing's syndrome shows high prevalence of extra-adrenal malignancy in patients with functioning bilateral adrenal tumors","volume":"61","author":"Kawate","year":"2014","journal-title":"Endocr J"},{"issue":"6","key":"2025031205572044000_lvaf028-B40","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0022-5347(01)68151-5","article-title":"Cleveland clinic experience with adrenal Cushing's syndrome","volume":"158","author":"Daitch","year":"1997","journal-title":"J Urol"},{"issue":"2","key":"2025031205572044000_lvaf028-B41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ecl.2018.02.007","article-title":"Genetics of Cushing's syndrome","volume":"47","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2018","journal-title":"Endocrinol Metab Clin North Am"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf028\/62164484\/lvaf028.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/3\/266\/62164484\/lvaf028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/3\/266\/62164484\/lvaf028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T01:57:28Z","timestamp":1741744648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/192\/3\/266\/8041897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf028","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,2,25]]}}}